{"changes":[],"country":"DK","description":"Orbis Medicines develops oral macrocycle drugs via its nGen platform, designing compounds called nCycles to turn injectable biologics into pills. It serves patients on biologic therapies and pharma partners seeking oral alternatives. A single design-make-test cycle generates up to 100,000 target-specific nCycles.","domain":"orbismedicines.com","employees":null,"founded":2022,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"bio","investors":[],"lat":55.686724,"lng":12.570072,"location":"Copenhagen, Denmark","name":"Orbis Medicines","rounds":[{"amountQuarantined":false,"amountUsd":28080000,"currency":"EUR","date":"2024-02-01","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"sifted","retrievedAt":"2026-06-07","status":"attributed","url":null},"status":"attributed","type":"seed","url":null}],"slug":"orbismedicines-com","sources":[{"fact":"round","publisher":"sifted","retrievedAt":"2026-06-07","status":"attributed","url":null},{"fact":"existence","publisher":"orbismedicines.com","retrievedAt":"2026-06-07","status":"self-reported","url":"https://orbismedicines.com"},{"fact":"description","publisher":"orbismedicines.com","retrievedAt":"2026-06-07","status":"self-reported","url":"https://orbismedicines.com"}],"stage":"seed","techStack":["@sentry/browser","adobe fonts","afterpay","hsts","moment 0","parallax.js","squarespace","squarespace commerce","stimulus","typekit","web-vitals"],"totalRaisedUsd":28080000,"updatedAt":"2026-06-07"}